Kontafarma China HKEX:1312:
LOSS FOR YEAR ATTRIBUTABLE HKD 427.8 MILLION
FY REVENUE HKD914.7 MILLION
Kontafarma China Posts Loss For Year Attributable HKD 427.8 Million
Kontafarma China Holdings Ltd on 6ix
Earlier from Kontafarma China
- Kontafarma China Expects FY2025 Consolidated Net Loss Of HK$414.1 Million-HK$506.2 Million
- Kontafarma China Says Qiao Linna Resigns As Executive Director, Vice President
Later from Kontafarma China
- Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr
- Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
- Grant of Waiver for further delay in despatch of circular under rule 14.41(a) of the listing rules
- Major transaction in relation to renewal of lease for fitness and yoga centre
- MAJOR TRANSACTION (Multi-Files)
Follow Kontafarma China into a list and get an email when it puts out news.
Follow Kontafarma China